Modelling the long-term benefits of photodynamic therapy (PDT) with Verteporfin for age-related macular degeneration (AMD)
Year of publication: |
2002-03
|
---|---|
Authors: | Smith, David ; Drummond, Mike ; Fenn, Paul |
Institutions: | Centre for Health Economics, Department of Economics and Related Studies |
Subject: | clinical trial | blindness | vision |
-
Disease Management Programs for Glaucoma: Has the Vision Become a Reality?
Goldberg, Lawrence D., (2007)
-
How Much is the Cost of Visual Impairment: the Author's Reply
Lafuma, Antoine, (2006)
-
How Much is the Cost of Visual Impairment: Caveat Emptor
Meads, Catherine, (2006)
- More ...
-
Use of economic evidence in the design of Health Improvement Programmes (HImPs)
Weatherly, Helen, (2002)
-
Measuring cost and quality of life in radiotherapy treatments
Morris, Jenny, (1993)
-
Making decisions about health technologies: a cost-effectiveness perspective
Rutten, Frans, (1994)
- More ...